Amarantus Bioscience Holdings Inc (AMBS)

[alexwv]

AMBS investment potential is in its diagnostic platform. Revenues by 4Q 2013, 1Q 2014. Estimated in the range of $150-175 million in the US alone. These patented/licensed diagnostics will detect neurodegenerative diseases much sooner and MANF will retain and restore key dopamine levels and maintain quality of life. Who would not view this sort of medicine as nothing but revolutionary!


What good is a healthy body, as our population ages, if the mind is hindering any quality of life? Ask yourself why there is so much focus on neurodegenerative diseases now? Where are the big pharma's going to turn?